NCT00389896View on ClinicalTrials.gov

A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 26, 2001

Primary Completion Date

October 4, 2002

Study Completion Date

October 4, 2002

Conditions

HDL Cholesterol

Interventions

DRUG

MK0733 / Duration of Treatment: 18 Weeks

DRUG

Comparator: placebo (unspecified) / Duration of Treatment: 18 Weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00389896 - A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED) | Biotech Hunter | Biotech Hunter